Rtw Investments, LP Global Blood Therapeutics, Inc. Transaction History

Rtw Investments, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$48.73 - $81.82 $35.1 Million - $58.9 Million	-719,489 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$41.72 - $87.2 $30 Million - $62.7 Million	719,489 New	719,489 $36.8 Million
Q2 2018 Aug 14, 2018	SELL	$38.7 - $50.15 $17.7 Million - $22.9 Million	-456,921 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$39.6 - $65.9 $5.73 Million - $9.54 Million	-144,762 Reduced 24.06%	456,921 $22.1 Million
Q4 2017 Feb 14, 2018	BUY	$29.7 - $45.7 $17.1 Million - $26.3 Million	575,373 Added 2186.9%	601,683 $23.7 Million
Q3 2017 Nov 14, 2017	BUY	$25.1 - $31.05 $660,381 - $816,925	26,310	26,310 $817,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Rtw Investments, LP with notifications on news.